date
coronaviru
diseas
pandem
affect
one
million
individu
countri
result
unpreced
health
social
econom
crise
http
coronavirusjhuedumaphtml
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
manifest
flulik
symptom
viral
pneumonia
progress
acut
respiratori
distress
syndrom
ard
even
multiorgan
failur
individu
elev
level
blood
neutrophil
earli
indic
infect
predict
sever
respiratori
diseas
wors
outcom
past
decad
group
mani
other
reveal
pathogen
role
neutrophilderiv
neutrophil
extracellular
trap
net
variou
thromboinflammatori
state
includ
sepsi
thrombosi
respiratori
failur
net
extracellular
web
dna
histon
microbicid
protein
oxid
enzym
releas
neutrophil
corral
infect
howev
properli
regul
net
potenti
initi
propag
inflamm
thrombosi
inde
inhibit
neutrophil
net
protect
variou
model
influenzaassoci
ard
although
yet
assess
whether
net
contribut
inflammatori
storm
lead
respiratori
failur
mani
patient
emerg
evid
implic
inflammatori
cytokin
interleukin
il
milieu
surprisingli
net
intim
intertwin
cytokin
especi
mani
pulmonari
cardiovascular
diseas
definit
account
pathophysiolog
like
await
develop
model
system
clear
pandem
virus
includ
influenza
sarscov
merscov
associ
neutrophil
infiltr
site
infect
develop
ard
acut
exud
phase
ard
character
exuber
immun
respons
product
proinflammatori
cytokin
chemokin
increas
neutrophil
infiltr
accumul
alveoli
disrupt
alveolar
epithelialcapillari
barrier
cultur
neutrophil
vitro
influenzainfect
lung
epitheli
cell
trigger
netosi
augment
endotheli
damag
cultur
supernat
neutrophildeplet
mice
demonstr
milder
lung
patholog
respons
influenza
infect
includ
lower
level
thrombomodulin
matrix
metalloproteinas
myeloperoxidas
mpo
bronchoalveolar
lavag
fluid
time
influenzainfect
mice
protect
serum
sampl
obtain
patient
hospit
larg
academ
hospit
tabl
compar
serum
sampl
healthi
control
sampl
show
higher
level
cellfre
dna
figur
myeloperoxidasedna
complex
mpodna
figur
citrullin
histon
figur
latter
two
marker
gener
regard
highli
specif
net
remnant
cellfre
dna
mpodna
demonstr
signific
correl
relationship
figur
associ
cellfre
dna
signific
figur
subset
patient
longitudin
serum
sampl
avail
level
net
marker
rel
stabl
sever
day
supplementari
figur
avail
sampl
includ
subsequ
correl
analys
summari
three
marker
indic
net
remnant
elev
sera
patient
compar
control
given
circul
net
may
driver
form
respons
blood
product
next
ask
aforement
net
marker
compar
sever
commonli
avail
clinic
test
specif
assess
potenti
correl
creactiv
protein
ddimer
lactat
dehydrogenas
absolut
net
associ
sever
diseas
includ
mechan
ventil
next
determin
clinic
statu
associ
avail
serum
sampl
compar
sampl
patient
sever
requir
mechan
ventil
sampl
patient
mild
moder
oxygen
satur
ambient
air
sampl
compar
patient
breath
room
air
patient
requir
mechan
ventil
significantli
higher
level
cellfre
dna
figur
mpodna
figur
figur
absolut
neutrophil
count
significantli
higher
ventil
patient
figur
summari
data
suggest
possibl
relationship
level
serum
net
sever
sera
trigger
control
neutrophil
releas
net
present
milieu
favor
netosi
reason
direct
exposur
control
neutrophil
patient
sera
without
addit
agonist
would
trigger
healthi
neutrophil
undergo
netosi
compar
heterolog
control
sera
patient
sera
robustli
promot
netosi
whether
measur
extern
dna
figur
releas
dnabound
mpo
enzym
figur
immunofluoresc
microscopi
demonstr
extracellular
chromatin
structur
decor
neutrophil
elastas
characterist
net
figur
summari
serum
sampl
patient
robustli
trigger
healthi
neutrophil
undergo
netosi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
report
first
time
elev
level
serum
net
mani
hospit
patient
measur
three
marker
commonli
use
detect
net
remnant
blood
cellfre
dna
mpodna
found
signific
elev
three
also
found
sera
potent
stimul
netosi
ad
control
neutrophil
togeth
data
provid
evid
least
hospit
patient
pronetot
state
trigger
netosi
potenti
myriad
requir
investig
possibl
includ
virusdamag
epitheli
cell
activ
platelet
activ
endotheli
cell
inflammatori
cytokin
granulocyt
coloni
stimul
factor
like
other
marker
test
cellfre
dna
close
associ
tradit
inflammatori
marker
use
track
includ
creactiv
protein
ddimer
lactat
dehydrogenas
notabl
although
cellfre
dna
highli
specif
marker
net
strongli
correl
absolut
neutrophil
count
specif
marker
net
mpodna
somewhat
unexpectedli
correl
well
two
marker
associ
strongli
platelet
level
believ
predomin
driver
histon
citrullin
ie
product
net
enzym
peptidlyarginin
deiminas
howev
neutrophil
trigger
undergo
netosi
varieti
stimuli
vitro
studi
demonstr
pathway
netosi
equal
reliant
activ
exampl
stimuli
lead
robust
reactiv
oxygen
speci
product
may
rel
dichotomi
mpodna
level
sera
test
potenti
suggest
two
pathway
netosi
activ
patient
pathway
lead
perhap
relationship
platelet
net
first
describ
novel
pathogen
erad
strategi
could
function
altern
phagocytosi
recogn
net
doubleedgedsword
properti
like
exacerb
case
even
initi
autoimmun
vascular
diseas
net
present
stabil
varieti
oxid
enzym
extracellular
space
includ
mpo
nadph
oxidas
nitric
oxid
synthas
also
serv
sourc
extracellular
histon
carri
signific
cytotox
potenti
light
toxic
cargo
surpris
net
play
role
varieti
lung
diseas
includ
cystic
fibrosi
occlud
larger
airway
smokingrel
lung
diseas
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
particular
relev
pathogeninduc
acut
lung
injuri
ard
net
also
well
studi
set
cardiovascular
diseas
infiltr
propag
inflamm
vessel
wall
form
intravascularli
occlud
arteri
vein
microscop
vessel
earli
studi
suggest
high
risk
morbid
arteri
event
one
specul
risk
venou
thrombosi
increasingli
reveal
data
becom
avail
sever
appear
defin
neutrophilia
well
elev
ddimer
latter
suggest
hyperact
coagul
system
find
signific
potenti
crosstalk
net
net
link
upstream
downstream
cardiovascular
pulmonari
diseas
includ
describ
group
venou
thrombosi
true
either
directli
perhap
intermediari
cours
discuss
exampl
net
driver
thrombosi
myriad
intravascular
netosi
respons
initi
accret
thrombot
event
arteri
vein
andparticularli
pertin
microvasculatur
thrombot
diseas
drive
endorgan
damag
lung
heart
kidney
organ
mechanist
net
via
electrostat
interact
activ
contact
pathway
coagul
also
present
tissu
factor
activ
intrins
pathway
simultan
serin
proteas
net
dismantl
natur
brake
coagul
tissu
factor
pathway
inhibitor
antithrombin
bidirect
interplay
net
platelet
may
also
critic
microvascular
thrombosi
character
varieti
diseas
model
interest
recent
small
studi
perform
china
suggest
potenti
efficaci
adenosinereceptor
agonist
dipyridamol
sever
case
dipyridamol
fdaapprov
drug
group
recent
discov
inhibit
net
format
activ
adenosin
receptor
aforement
trial
patient
bilater
pneumonia
treat
oral
dipyridamol
seven
day
addit
treatment
antivir
agent
compar
control
dipyridamoletr
patient
demonstr
improv
platelet
count
ddimer
level
given
urgent
need
effect
treatment
random
studi
character
impact
dipyridamol
netosi
thromboinflammatori
storm
cours
outcom
may
warrant
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
approach
combat
net
review
includ
dismantl
alreadyform
net
deoxyribonucleas
strategi
might
prevent
initi
net
releas
includ
inhibitor
neutrophil
elastas
studi
certainli
limit
includ
use
serum
plasma
typic
prefer
group
other
measur
net
rel
small
sampl
size
hope
ignit
research
role
neutrophil
effector
function
complic
first
step
futur
studi
investig
predict
power
circul
net
wellphenotyp
longitudin
cohort
furthermor
given
dichotomi
found
mpodna
investig
encourag
continu
includ
divers
marker
netosi
futur
studi
await
definit
antivir
immunolog
solut
current
pandem
posit
antineutrophil
therapi
may
part
person
strategi
individu
affect
risk
progress
respiratori
failur
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
use
studi
blood
collect
serum
separ
tube
contain
clot
activ
serum
separ
gel
train
hospit
phlebotomist
complet
biochem
test
order
clinician
remain
serum
store
hour
deem
discard
releas
research
laboratori
serum
sampl
immedi
divid
small
aliquot
store
time
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
hrpconjug
cell
death
kit
dilut
block
buffer
five
wash
plate
develop
tmb
substrat
invitrogen
follow
sulfur
acid
stop
solut
absorb
measur
wavelength
nm
use
cytat
cell
imag
multimod
reader
biotek
data
normal
vitroprepar
net
standard
includ
everi
plate
quantifi
base
dna
content
human
neutrophil
purif
neutrophil
prepar
blood
healthi
volunt
collect
sodium
citrat
tube
standard
phlebotomi
techniqu
anticoagul
blood
fraction
densitygradi
centrifug
use
ficollpaqu
plu
ge
healthcar
neutrophil
purifi
dextran
sediment
red
blood
cell
layer
lyse
residu
red
blood
cell
sodium
chlorid
neutrophil
prepar
least
pure
confirm
nuclear
morpholog
cellimperm
dye
sytox
green
thermo
fisher
use
measur
netosi
briefli
purifi
neutrophil
resuspend
pb
gibco
neutrophil
seed
well
polyllysin
sigma
coat
black
clearbottom
nontissu
cultur
plate
costar
allow
adher
minut
pb
gentli
remov
controlpati
serum
dilut
rpmi
cultur
media
supplement
lglutamin
care
ad
without
disrupt
adher
cell
sytox
green
ad
time
final
concentr
nm
treatment
done
triplic
cell
allow
undergo
netosi
hour
cultur
media
gentli
remov
fresh
pb
ad
well
fluoresc
quantifi
excit
emiss
wavelength
nm
nm
respect
use
cytat
cell
imag
multimod
reader
biotek
data
collect
use
areascan
set
plate
reader
purifi
neutrophil
resuspend
rpmi
media
gibco
supplement
bovin
serum
albumin
bsa
sigma
heatinactiv
fetal
bovin
serum
fb
gibco
lglutamin
neutrophil
x
well
cultur
tissu
cultur
plate
costar
presenc
either
patient
control
serum
dilut
final
concentr
plate
incub
hour
collect
netassoci
mpo
cultur
media
discard
remov
solubl
mpo
replac
pb
supplement
uml
micrococc
nucleas
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
thermo
fisher
minut
c
digest
net
stop
mm
edta
supernat
transfer
vshape
well
plate
centrifug
minut
remov
debri
supernat
transfer
new
flatbottom
plate
quantifi
mpo
activ
equal
volum
tmb
substrat
thermo
fisher
ad
well
minut
incub
dark
reaction
stop
sulfur
acid
solut
absorb
measur
nm
use
cytat
cell
imag
multimod
reader
netosi
assay
microscopi
immunofluoresc
microscopi
neutrophil
seed
onto
coverslip
coat
polyllysin
sigma
cultur
assay
sampl
fix
paraformaldehyd
minut
room
temperatur
follow
block
fb
pb
primari
antibodi
neutrophil
elastas
abcam
dilut
fitcconjug
secondari
antibodi
southernbiotech
dilut
dna
stain
hoechst
invitrogen
imag
collect
cytat
cell
imag
multimod
reader
statist
analysi
normallydistribut
data
analyz
twosid
test
skew
data
analyz
mannwhitney
test
data
analysi
graphpad
prism
softwar
version
correl
test
pearson
correl
coeffici
statist
signific
defin
p
unless
state
otherwis
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
